Diversified Trust CO Agenus Inc Transaction History

Diversified Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$0.63 - $1.14 $661 - $1,197	-1,050 Reduced 1.77%	58,252 $48,000
Q3 2023 Nov 17, 2023	BUY	$1.12 - $1.88 $1,176 - $1,974	1,050 Added 1.8%	59,302 $67,000
Q2 2023 Jul 18, 2023	BUY	$1.31 - $2.04 $45,467 - $70,804	34,708 Added 147.42%	58,252 $93,000
Q3 2022 Oct 14, 2022	BUY	$1.96 - $3.14 $46,146 - $73,928	23,544 New	23,544 $48,000
Q2 2022 Jul 12, 2022	SELL	$1.3 - $2.64 $39,978 - $81,187	-30,753 Closed	0 $0
Q1 2022 Apr 07, 2022	SELL	$2.35 - $3.47 $23,641 - $34,908	-10,060 Reduced 24.65%	30,753 $76,000
Q4 2021 Jan 13, 2022	BUY	$2.92 - $5.74 $29,375 - $57,744	10,060 Added 32.71%	40,813 $131,000
Q1 2021 May 10, 2021	BUY	$2.69 - $5.25 $17,463 - $34,083	6,492 Added 26.76%	30,753 $84,000
Q2 2020 Jul 07, 2020	BUY	$2.29 - $4.24 $55,557 - $102,866	24,261 New	24,261 $95,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.